Zoetis Inc. (ZTS)
NYSE: ZTS · Real-Time Price · USD
147.53
+1.59 (1.09%)
At close: Oct 27, 2025, 4:00 PM EDT
147.60
+0.07 (0.05%)
After-hours: Oct 27, 2025, 5:06 PM EDT
Zoetis Employees
Zoetis had 13,800 employees as of December 31, 2024. The number of employees decreased by 300 or -2.13% compared to the previous year.
Employees
13,800
Change (1Y)
-300
Growth (1Y)
-2.13%
Revenue / Employee
$680,072
Profits / Employee
$189,275
Market Cap
65.38B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13,800 | -300 | -2.13% |
| Dec 31, 2023 | 14,100 | 300 | 2.17% |
| Dec 31, 2022 | 13,800 | 1,700 | 14.05% |
| Dec 31, 2021 | 12,100 | 800 | 7.08% |
| Dec 31, 2020 | 11,300 | 700 | 6.60% |
| Dec 31, 2019 | 10,600 | 600 | 6.00% |
| Dec 31, 2018 | 10,000 | 800 | 8.70% |
| Dec 31, 2017 | 9,200 | 200 | 2.22% |
| Dec 31, 2016 | 9,000 | 0 | - |
| Dec 31, 2015 | 9,000 | -1,000 | -10.00% |
| Dec 31, 2014 | 10,000 | 200 | 2.04% |
| Dec 31, 2013 | 9,800 | 500 | 5.38% |
| Dec 31, 2012 | 9,300 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ZTS News
- 6 days ago - Zoetis Stock: Outlook Remains Muted - Benzinga
- 12 days ago - Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs - Business Wire
- 17 days ago - Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs - Business Wire
- 18 days ago - Zoetis Declares Fourth Quarter 2025 Dividend - Business Wire
- 24 days ago - Top 50 High-Quality Dividend Growth Stocks For October 2025 - Seeking Alpha
- 25 days ago - Top 15 High-Growth Dividend Stocks For October 2025 - Seeking Alpha
- 27 days ago - Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle - Business Wire
- 4 weeks ago - Pet Pain For Investor Gain - Seeking Alpha